A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. (Q47568717)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

anti-retroviral agent

0 references

Michael C. Sneller

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Katherine E Clarridge

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Michael Proschan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Jana Blažková

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Eric W Refsland

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

21

object named as

Anthony S Fauci

1 reference

Europe PubMed Central

5 April 2020

18

object named as

Colin Kovacs

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

4

object named as

Mary E Petrone

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

8

object named as

Victoria Shi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Kathleen R Gittens

3

object named as

Kathleen R Gittens

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

7

object named as

Richard Kwan

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

J Shawn Justement

2

object named as

J Shawn Justement

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Michael A Egan

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

John H Eldridge

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Erika Benko

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Susan Moir

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

0 references

publication date

1 December 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Science Translational Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

419

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Antiretroviral therapy and management of HIV infection

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

HIV reservoirs as obstacles and opportunities for an HIV cure

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation: HIV rebound with current ART appears to be due to infection with new endogenous founder virus and not to resurgence of pre-existing Tat-dependent v

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Immunology. Immune activation with HIV vaccines

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

No evidence of posttreatment control after early initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Short-course antiretroviral therapy in primary HIV infection

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

HIV incidence determination in the United States: a multiassay approach

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

OMIP-014: validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAN8848

21 January 2018

Identifiers

10.1126/SCITRANSLMED.AAN8848

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29212716%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47568717&oldid=1858767652"